Henry F. McFarland

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

W. I. McDonald, Alistair Compston, Gilles Edan et al. · Annals of Neurology · 2001 · 7K citations

Medicine, Internal Medicine, Neurology +10

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

Bibiana Bielekova, Bonnie L. Goodwin, Nancy Richert et al. · Nature Medicine · 2000 · 826 citations

Life Sciences, Neurology, Neuroscience +17

Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

Kevin G. Becker, Richard Simon, Joan E. Bailey‐Wilson et al. · Proceedings of the National Academy of Sciences · 1998 · 595 citations

Life Sciences, Genetics, Immunology +17

Regulatory CD56 ^bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis

Bibiana Bielekova, Marta Catálfamo, Susan Reichert-Scrivner et al. · Proceedings of the National Academy of Sciences · 2006 · 593 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

Paolo A. Muraro, Daniel C. Douek, Katherine Chung et al. · The Journal of Experimental Medicine · 2005 · 498 citations · Full text

Life Sciences, Immunology, Pathobiology +17